艾万拓
AVTR
16.42
+0.33
+2.05%
艾万拓
US · AVTR
#1438 按市值排名
上市于 2019
16.42
+0.33
+2.05%
实时 - 追踪5344个代码 - 心跳于482秒前
· 2026-10-16 19:30
✦ 量化股权信号 计算方式说明
涨跌不一/平稳
- 最近一期（2026/Q3）披露持股的机构数量减少了2家。
- 机构持股总比例基本持平。
机构持股
- 机构持股比例
- 104.19% -0.02pp
- 机构数量
- 533 -2
- 数据截至
- 2026/Q3 较上一报告期
持股变动 vs 资金流向
方向一致机构在上一报告期减持了股份，同时该股在最近20个交易日的主力资金呈净流出——两者方向一致。
机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。
持股人类型
Mutual Fund84.29%
Hedge Fund13.04%
Private Company2.50%
Public Company1.98%
Government Pension Fund1.00%
Sovereign Wealth Fund0.90%
Individual/Insider0.58%
Insurance Company0.17%
Family Office/Trust0.15%
主要股东 截至 2026-06-30
Dodge & Cox
17.75% · 120.02M 股
BlackRock
10.39% · 70.28M 股
Vanguard Capital Management, LLC
5.19% · 35.13M 股
Vanguard Portfolio Management, LLC
4.63% · 31.34M 股
Greenhaven Associates Inc
3.64% · 24.64M 股
State Street Global Advisors
3.19% · 21.57M 股
Dimensional Fund Advisors
3.02% · 20.41M 股
Engine Capital Management, LP
2.94% · 19.86M 股
Barrow, Hanley, Mewhinney & Strauss, LLC
2.92% · 19.74M 股
New Mountain Capital Group, L.P.
2.07% · 14.00M 股
条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。
内部人持股
共追踪50份申报 · 34次买入 · 16次卖出
| 姓名 | 职务 | 持股比例 |
|---|---|---|
| Michael Stubblefield | Chief Executive Officer | 0.26% |
| Sanjeev Mehra | Director | 0.07% |
| Gregory Summe | Independent Director | 0.07% |
| Brittany Hankamer | Chief Human Resources Officer | 0.04% |
| Jonathan Peacock | Independent Chairperson | 0.03% |
| Steven Eck | Senior VP, Corporate Controller & Chief Accounting Officer | 0.02% |
| Emmanuel Ligner | President | 0.02% |
| Gregory Lucier | Director | 0.01% |
| Christophe Couturier | Executive Vice President of AMEA | 0.01% |
| Juan Andres | Independent Director | 0.01% |
内部人交易 最近的 Form 4 申报记录
| 日期 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-09-20 | Todd Garner | Chief Financial Officer | Other Acquisition | +49,688 | -- |
| 2026-09-20 | Todd Garner | Chief Financial Officer | Other Derivative Acquisition | +138,632 | $16.61 |
| 2026-08-17 | Emmanuel Ligner | President | Sale to Issuer | -29,803 | $13.33 |
| 2026-08-13 | Brittany Hankamer | Chief Human Resources Officer | Sale to Issuer | -181 | $13.66 |
| 2026-07-30 | Steven Eck | Senior VP, Corporate Controller & Chief Accounting Officer | Sale to Issuer | -1,385 | $13.78 |
| 2026-07-23 | Claudius Sokenu | Executive VP, Corporate Secretary and Chief Legal & Compliance Officer | Sale to Issuer | -1,201 | $11.44 |
| 2026-06-20 | Corey Walker | Former Executive Vice President of Americas | Sale to Issuer | -3,010 | $9.58 |
| 2026-05-07 | Gregory Lucier | Director | Open Market Acquisition | +10,000 | $8.32 |
| 2026-05-06 | Gregory Summe | Independent Director | Other Acquisition | +25,270 | -- |
| 2026-05-06 | Sanjeev Mehra | Director | Other Acquisition | +25,270 | -- |
| 2026-05-06 | Simon Dingemans | Director | Other Acquisition | +25,270 | -- |
| 2026-05-06 | Gregory Lucier | Director | Other Acquisition | +25,270 | -- |
| 2026-05-06 | Pamela Makin | Director | Other Acquisition | +25,270 | -- |
| 2026-05-06 | Joseph Massaro | Independent Director | Other Acquisition | +25,270 | -- |
| 2026-05-06 | Michael Severino | Independent Director | Other Acquisition | +25,270 | -- |
| 2026-05-06 | Mala Murthy | Independent Director | Other Acquisition | +25,270 | -- |
| 2026-04-30 | Simon Dingemans | Director | Open Market Acquisition | +25,000 | $8.14 |
| 2026-04-30 | Ludovic Brellier | EVP of Bioscience & Medtech Products and Chief Transformation Officer | Other Acquisition | +146,566 | -- |
| 2026-04-30 | Ludovic Brellier | EVP of Bioscience & Medtech Products and Chief Transformation Officer | Other Derivative Acquisition | +246,002 | $8.76 |
| 2026-04-02 | Steven Eck | Senior VP, Corporate Controller & Chief Accounting Officer | Other Acquisition | +31,645 | -- |
Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。
报价时间 2026-10-16 19:30:04 · 仅供参考，不构成投资建议，也未考虑您的具体情况。
艾万拓 讨论区 0 条评论